| Literature DB >> 33151608 |
Yan Long1, Bei Cao2, Xiaolin Xiong1, Albert S C Chan1, Raymond Wai-Yin Sun3, Taotao Zou1,4,5.
Abstract
Controllably activating the bio-reactivity of metal complexes in living systems is challenging but highly desirable because it can minimize off-target bindings and improve spatiotemporal specificity. Herein, we report a new bioorthogonal activation approach by employing Pd(II)-triggered transmetallation reactions to conditionally activate the bio-reactivity of NHC-Au(I)-phenylacetylide complexes (1 a) in vitro and in vivo. A combination of 1 H NMR, LC-MS, DFT calculation and fluorescence screening assays reveals that 1 a displays a reasonable stability against biological thiols, but its phenylacetylide ligand can be efficiently transferred to Pd(II), leading to in situ formation of labile NHC-Au(I) species that is catalytically active inside living cells and zebrafish, and can meanwhile effectively suppress the activity of thioredoxin reductase, potently inhibit the proliferation of cancer cells and efficiently suppress angiogenesis in zebrafish models.Entities:
Keywords: anti-cancer; bioorthogonal activation; gold medicine; in-cell catalysis; thiol reactivity
Year: 2020 PMID: 33151608 DOI: 10.1002/anie.202013366
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336